121 related articles for article (PubMed ID: 6601679)
1. Association of HLA-DR5 with mycosis fungoides.
Safai B; Myskowski PL; Dupont B; Pollack MS
J Invest Dermatol; 1983 May; 80(5):395-7. PubMed ID: 6601679
[TBL] [Abstract][Full Text] [Related]
2. Frequencies of HLA and Gm immunogenetic markers in Kaposi's sarcoma.
Pollack MS; Safai B; Myskowski PL; Gold JW; Pandey J; Dupont B
Tissue Antigens; 1983 Jan; 21(1):1-8. PubMed ID: 6601312
[TBL] [Abstract][Full Text] [Related]
3. HLA-DR5 and DQB1*03 class II alleles are associated with cutaneous T-cell lymphoma.
Jackow CM; McHam JB; Friss A; Alvear J; Reveille JR; Duvic M
J Invest Dermatol; 1996 Sep; 107(3):373-6. PubMed ID: 8751973
[TBL] [Abstract][Full Text] [Related]
4. Histocompatibility antigens HLA-A, -B, -DR in Greek patients with Kaposi's sarcoma.
Papasteriades C; Kaloterakis A; Filiotou A; Economidou J; Nicolis G; Trichopoulos D; Stratigos J
Tissue Antigens; 1984 Nov; 24(5):313-5. PubMed ID: 6335794
[TBL] [Abstract][Full Text] [Related]
5. HLA studies in acquired immune deficiency syndrome patients with Kaposi's sarcoma.
Prince HE; Schroff RW; Ayoub G; Han S; Gottlieb MS; Fahey JL
J Clin Immunol; 1984 May; 4(3):242-5. PubMed ID: 6588054
[TBL] [Abstract][Full Text] [Related]
6. Human leukocyte antigens in cutaneous T cell lymphoma.
Rosen ST; Radvany R; Roenigk H; Terasaki PI; Bunn PA
J Am Acad Dermatol; 1985 Mar; 12(3):531-4. PubMed ID: 3872893
[TBL] [Abstract][Full Text] [Related]
7. HLA studies of endemic African Kaposi's sarcoma patients and matched controls: no association with HLA-DR5.
Melbye M; Kestens L; Biggar RJ; Schreuder GM; Gigase PL
Int J Cancer; 1987 Feb; 39(2):182-4. PubMed ID: 3492448
[TBL] [Abstract][Full Text] [Related]
8. Primary cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome): part I. Diagnosis: clinical and histopathologic features and new molecular and biologic markers.
Jawed SI; Myskowski PL; Horwitz S; Moskowitz A; Querfeld C
J Am Acad Dermatol; 2014 Feb; 70(2):205.e1-16; quiz 221-2. PubMed ID: 24438969
[TBL] [Abstract][Full Text] [Related]
9. HLA and Kaposi's sarcoma in Sardinia.
Contu L; Cerimele D; Pintus A; Cottoni F; La Nasa G
Tissue Antigens; 1984 Apr; 23(4):240-5. PubMed ID: 6587615
[TBL] [Abstract][Full Text] [Related]
10. Mycosis fungoides: HLA class II associations among Ashkenazi and non-Ashkenazi Jewish patients.
Hodak E; Lapidoth M; Kohn K; David D; Brautbar B; Kfir K; Narinski N; Safirman S; Maron M; Klein K
Br J Dermatol; 2001 Dec; 145(6):974-80. PubMed ID: 11899152
[TBL] [Abstract][Full Text] [Related]
11. Pediatric mycosis fungoides: a study of the human leukocyte antigen system among Israeli Jewish patients.
Reiter O; Ben Amitai D; Amitay-Laish I; Israeli M; Pavlovsky L; Hodak E
Arch Dermatol Res; 2017 Dec; 309(10):851-856. PubMed ID: 28948342
[TBL] [Abstract][Full Text] [Related]
12. Human T-cell leukemia virus type I or a related retrovirus in patients with mycosis fungoides/Sézary syndrome and Kaposi's sarcoma.
Srivastava BI; Banki K; Perl A
Cancer Res; 1992 Aug; 52(16):4391-5. PubMed ID: 1353704
[TBL] [Abstract][Full Text] [Related]
13. Immunogenetic factors in mycosis fungoides: can the HLA system influence the susceptibility and prognosis of the disease? Long-term follow-up study of 46 patients.
Brazzelli V; Rivetti N; Badulli C; Carugno A; Grasso V; De Silvestri A; Martinetti M; Borroni G
J Eur Acad Dermatol Venereol; 2014 Dec; 28(12):1732-7. PubMed ID: 24533560
[TBL] [Abstract][Full Text] [Related]
14. HLA in familial and nonfamilial Mediterranean Kaposi's sarcoma in Greece.
Kaloterakis A; Papasteriades C; Filiotou A; Economidou J; Hadjiyannis S; Stratigos J
Tissue Antigens; 1995 Feb; 45(2):117-9. PubMed ID: 7792757
[TBL] [Abstract][Full Text] [Related]
15. Kaposi's sarcoma and the HLA-Dr5 alloantigen.
Ohara N; Chang SW
Ann Intern Med; 1982 Oct; 97(4):617. PubMed ID: 6982016
[No Abstract] [Full Text] [Related]
16. Immunologic and immunogenetic features of primary Kaposi's sarcoma.
Marinig C; Fiorini G; Boneschi V; Melotti E; Brambilla L
Cancer; 1985 May; 55(9):1899-901. PubMed ID: 3156665
[TBL] [Abstract][Full Text] [Related]
17. Mycosis fungoides/Sézary syndrome: report of an unusual case.
Mehta A; Dhungel BM; Khan MF
J Cutan Pathol; 2006 Sep; 33 Suppl 2():12-5. PubMed ID: 16972946
[TBL] [Abstract][Full Text] [Related]
18. [HLA typing in classical and African Kaposi's disease].
Lemarchand-Venencie F; Lepace V; Belaich S; Civatte J; Rabian C; Chidiac A; Colombani J; Degos L
Pathol Biol (Paris); 1986 Jun; 34(6):761-4. PubMed ID: 3531992
[TBL] [Abstract][Full Text] [Related]
19. Immune evasion and current immunotherapy strategies in mycosis fungoides (MF) and Sézary syndrome (SS).
Shalabi D; Bistline A; Alpdogan O; Kartan S; Mishra A; Porcu P; Nikbakht N
Chin Clin Oncol; 2019 Feb; 8(1):11. PubMed ID: 30691274
[TBL] [Abstract][Full Text] [Related]
20. Familial mycosis fungoides: report of 6 kindreds and a study of the HLA system.
Hodak E; Klein T; Gabay B; Ben-Amitai D; Bergman R; Gdalevich M; Feinmesser M; Maron L; David M
J Am Acad Dermatol; 2005 Mar; 52(3 Pt 1):393-402. PubMed ID: 15761416
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
